155497-10-2 Usage
Uses
Used in Pharmaceutical Industry:
1-Benzyl-3-Boc-aminomethylpyrrolidine is used as a building block for the preparation of various pharmaceuticals and biologically active molecules. Its unique structure allows for the development of new synthetic methodologies and the creation of diverse molecular structures for drug discovery.
Used in Organic Synthesis:
1-Benzyl-3-Boc-aminomethylpyrrolidine is used as a starting material for the synthesis of other functionalized pyrrolidine derivatives with potential medicinal properties. Its presence in organic synthesis aids in the development of new compounds with therapeutic applications.
Used in Material Science Applications:
As a chemical reagent, 1-Benzyl-3-Boc-aminomethylpyrrolidine has been utilized in the creation of diverse molecular structures for material science applications, contributing to the advancement of new materials with specific properties and functions.
Check Digit Verification of cas no
The CAS Registry Mumber 155497-10-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,5,4,9 and 7 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 155497-10:
(8*1)+(7*5)+(6*5)+(5*4)+(4*9)+(3*7)+(2*1)+(1*0)=152
152 % 10 = 2
So 155497-10-2 is a valid CAS Registry Number.
InChI:InChI=1/C17H26N2O2/c1-17(2,3)21-16(20)18-11-15-9-10-19(13-15)12-14-7-5-4-6-8-14/h4-8,15H,9-13H2,1-3H3,(H,18,20)
155497-10-2Relevant academic research and scientific papers
Indole, azaindole and related heterocyclic pyrrolidine derivatives
-
Page 27, (2008/06/13)
This invention provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the invention is concerned with amido piperazine derivatives. These compounds possess unique antiviral activity
Pyrrolidine derivatives-CCR-3 receptor antagonists
-
, (2008/06/13)
This invention relates to certain 3-aminomethylpyrrolidine derivatives of Formula (I): that are CCR-3 receptor antagonists, pharmaceutical compositions containing them, methods for their use and methods for preparing these compounds.
